Last reviewed · How we verify
NCT06973200: NTDs_SAC
Burden of Schistosomiasis and Soil-transmitted Helminth Infections in Schoolchildren in Banfora, Burkina Faso
trial testing Dihydroartemisin-piperaquine in Schistosomiasis in Children in 300 participants. Completed in 25 February 2025.
21 December 2024
Quick facts
| Lead sponsor | Centre MURAZ/Institut National de Santé Publique |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 300 |
| Start date | 11 November 2024 |
| Primary completion | 21 December 2024 |
| Estimated completion | 25 February 2025 |
| Sites | 1 location across Burkina Faso |
Drugs / interventions tested
- Dihydroartemisin-piperaquine — full drug profile →
Conditions studied
- Schistosomiasis in Children — all drugs for Schistosomiasis in Children →
- Soil Transmitted Helminth (STH) Infections — all drugs for Soil Transmitted Helminth (STH) Infections →
- Malaria Infection — all drugs for Malaria Infection →
- Anaemia — all drugs for Anaemia →
Sponsor
Centre MURAZ/Institut National de Santé Publique
Who can join
Adults 5 to 15, any sex, with Schistosomiasis in Children or Soil Transmitted Helminth (STH) Infections. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A cross-sectional study will be conducted among 300 schoolchildren in the Banfora region, including 120 in urban and 180 in rural areas, to assess the prevalence of schistosomiasis and soil-transmitted helminth infections. All children with S. mansoni and/or S. haematobium infections at enrolment will then be treated with dihydroartemisinin-piperaquine (DP) and followed up on days 1, 2, 3, 4, 28, and 42 to assess the efficacy and safety of DP. At the end of the study, all children (infected and uninfected) will receive praziquantel and albendazole according to national recommendations.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06973200
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Dihydroartemisin-piperaquine
Trials testing the same drug.
- NCT07362498 — Health Systems Implementation and Molecular Surveillance of Multiple First-Line Treatments for Uncomplicated Malaria in · completed
Other Centre MURAZ/Institut National de Santé Publique trials
Trials by the same sponsor.
- NCT06572644 — Performance of an Ultrasensible Malaria Rapid Diagnostic Test Among Pregnant Women in Burkina Faso · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06973200 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre MURAZ/Institut National de Santé Publique
- Last refreshed: 15 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06973200.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing